Abbott’s $5 Rapid Covid Test Takes $22 Billion Bite Out of Peers

(Bloomberg) -- The U.S. emergency authorization for Abbott Laboratories’ rapid Covid-19 test sent competitors spiraling, wiping out at least $22 billion in market value across more than a dozen com...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.